Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now later-stage tilt small index

Adiposity: later-stage trial registry

5 of 12 indexed Adiposity trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 5 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Adiposity: 12 US clinical trials tracked, 5 recruiting.

Adiposity is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 2 of these trials.

Enrollment posture brief

Registry condition adiposity

OPEN 5 | RECR 42% | LATE 3 | EARLY 0 | RANK #1429 | SPON 2

Nearest open-share peer: Alzheimer Disease, Early Onset (42% recruiting · 12 trials)

Adiposity (this)42%Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Adiposity

Adiposity lists 5 open slots (42% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adiposity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adiposity is recruiting below its size-band peers.

    5 of 12 indexed trials (41.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Adiposity research.

    University of Colorado, Denver accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Most Adiposity trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 12 trials that report a genuine target (sentinel values excluded). 9 of those (75%) plan for fewer than 100 participants.

  4. Adiposity research is mostly interventional.

    12 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 43

Open and recent trials

12 total, page 1 of 1

RECRUITING NA 150 participants

The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)

Arkansas Children's Hospital Research Institute

NCT05992688

RECRUITING Phase 4 100 participants

Cardiometabolic Consequences of the Loss of Ovarian Function

University of Colorado, Denver

NCT06264882

RECRUITING NA 70 participants

Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

University of Colorado, Denver

NCT06129110

RECRUITING NA 32 participants

Redefining BMI: The Body, Mind, and Inflammation Trial

Virginia Commonwealth University

NCT06532747

RECRUITING NA 5 participants

The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health

University of California, Davis

NCT06476795

ACTIVE NOT RECRUITING NA 50 participants

Serial Assessment of Body Fat Accrual in Very Preterm Infants

University of Alabama at Birmingham

NCT03575897

ACTIVE NOT RECRUITING NA 15 participants

Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy

Erbe Elektromedizin

NCT05486338

COMPLETED NA 578 participants

Healthy Mothers-Healthy Children Nutrition

University of Miami

NCT03866902

COMPLETED NA 54 participants

Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects

Texas State University, San Marcos

NCT02151825

COMPLETED Phase 4 30 participants

Kybella With Triamcinolone

Goldman, Butterwick, Fitzpatrick and Groff

NCT03361176

COMPLETED NA 12 participants

The Effects of Alcohol Consumption on Central Adiposity

Pennington Biomedical Research Center

NCT03521817

COMPLETED Phase 4 10 participants

Kybella for the Treatment of Flank Fat (FF)

Beer, Kenneth R., M.D., PA

NCT04841551

Phase Distribution

PhaseTrial count
Phase 4 3

Named interventions

Most-linked intervention names on Adiposity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Synbiotic Dietary supplement
1 trials
Kybella Flanks Drug
1 trials
English for Second Language Intervention Other
1 trials
Nutrition and Physical Activity Intervention Behavioral
1 trials
Injectable sodium deoxycholate with Triamcinolone acetate Combination
1 trials
Injectable sodium deoxycholate Drug
1 trials
No Alcohol Other
1 trials
Hybrid Argon Plasma Coagulation (HAPC) Device
1 trials

US sites by state

Facility locations filed on Adiposity trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Florida 2 trials
Colorado 2 trials
California 2 trials
Virginia 1 trials
Texas 1 trials
Maryland 1 trials
Louisiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Adiposity page

12 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adiposity condition card totals 12 registered trials; most-linked intervention Synbiotic; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.